Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics.
暂无分享,去创建一个
C. Scott | G. Lindeman | Y. Antill | A. Hamilton | C. Wrede | M. Kentwell | O. Mcnally | E. Higgs | S. Ananda | E. Dow | O. McNally | Eryn Dow | Clare L. Scott | Geoffrey J. Lindeman | C. David Wrede
[1] Anne Floquet,et al. Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial. , 2017, The Lancet. Oncology.
[2] D. Matei,et al. Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial. , 2016, The Lancet. Oncology.
[3] N. Rahman,et al. The integration of BRCA testing into oncology clinics. , 2016, British journal of nursing.
[4] N. Pachter,et al. Impact of Clinical Genetics Attendance at a Gynecologic Oncology Tumor Board on Referrals for Genetic Counseling and BRCA Mutation Testing , 2016, International Journal of Gynecologic Cancer.
[5] B. Monk,et al. A randomized, double-blind phase III trial of niraparib maintenance treatment in patients with HRD+ advanced ovarian cancer after response to front-line platinum-based chemotherapy. , 2016 .
[6] B. Karlan,et al. Evolving Approaches in Research and Care for Ovarian Cancers: A Report From the National Academies of Sciences, Engineering, and Medicine. , 2016, JAMA.
[7] S. Seal,et al. Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients , 2016, Scientific Reports.
[8] J. Abraham,et al. Understanding of BRCA VUS genetic results by breast cancer specialists , 2015, BMC Cancer.
[9] E. Smets,et al. Non-genetic health professionals’ attitude towards, knowledge of and skills in discussing and ordering genetic testing for hereditary cancer , 2015, Familial Cancer.
[10] P. Bruzzi,et al. Referral of Ovarian Cancer Patients for Genetic Counselling by Oncologists: Need for Improvement , 2015, Public Health Genomics.
[11] C. Scott,et al. Poly (ADP-ribose) polymerase inhibitors: recent advances and future development. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] K. Robison,et al. Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals. , 2012, Gynecologic oncology.
[13] Sokbom Kang,et al. Completeness of pedigree and family cancer history for ovarian cancer patients , 2014, Journal of gynecologic oncology.
[14] P. DiSilvestro,et al. SOLO1 and SOLO2: Randomized phase III trials of olaparib in patients (pts) with ovarian cancer and a BRCA1/2 mutation (BRCAm). , 2014 .
[15] J. Garber,et al. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] R. Vogel,et al. Genetic Risk Assessment for Women with Epithelial Ovarian Cancer: Referral Patterns and Outcomes in a University Gynecologic Oncology Clinic , 2013, Journal of Genetic Counseling.
[17] M. Friedlander,et al. Communication and information needs of women diagnosed with ovarian cancer regarding treatment-focused genetic testing. , 2013, Oncology nursing forum.
[18] J. George,et al. BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] D. Matei,et al. Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer. , 2012, The New England journal of medicine.
[20] B. Meiser,et al. There is no decision to make: experiences and attitudes toward treatment-focused genetic testing among women diagnosed with ovarian cancer. , 2012, Gynecologic oncology.
[21] L. Wilkins-Haug,et al. Obstetrician-gynecologists' opinions and attitudes on the role of genetics in women's health. , 2000, Journal of women's health & gender-based medicine.
[22] J. Rogers,et al. The semi-structured genogram interview. I: Protocol. II: Evaluation. , 1984 .